Anbio Biotechnology
NNNN
$6.57
$0.192.98%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.50M | 8.11M | 6.71M | 7.74M | 8.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.50M | 8.11M | 6.71M | 7.74M | 8.76M |
| Cost of Revenue | 4.03M | 3.69M | 3.35M | 3.96M | 4.57M |
| Gross Profit | 5.47M | 4.42M | 3.36M | 3.78M | 4.19M |
| SG&A Expenses | 1.07M | 1.17M | 1.27M | 1.90M | 2.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.36M | 5.06M | 4.75M | 6.03M | 7.31M |
| Operating Income | 4.14M | 3.05M | 1.96M | 1.71M | 1.45M |
| Income Before Tax | 4.33M | 3.29M | 2.25M | 1.89M | 1.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.33 | 3.29 | 2.25 | 1.89 | 1.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.33M | 3.29M | 2.25M | 1.89M | 1.52M |
| EBIT | 4.14M | 3.05M | 1.96M | 1.71M | 1.45M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.09 | 0.05 | 0.02 | 0.01 | 0.01 |
| Normalized Basic EPS | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.09 | 0.05 | 0.02 | 0.01 | 0.01 |
| Normalized Diluted EPS | 0.06 | 0.03 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 369.16M | 469.16M | 569.16M | 426.87M | 284.58M |
| Average Diluted Shares Outstanding | 369.16M | 469.16M | 569.16M | 426.87M | 284.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |